BGDO | Belgian Group of Digestive Oncology

  • Plein écran
  • Ecran large
  • Ecran étroit
  • Increase font size
  • Default font size
  • Decrease font size

BGDO | Belgian Group of Digestive Oncology

Welcome - News

E-mail Print PDF

Upcoming Events

-> BGDO Annual Meeting - Saturday 9 January 2016  -   Leuven
.... Quality Indicators - Health Economics in GI Oncology - Online Registration

-> BGDO session at the Belgian Week of Gastroenterology - Fr. 29 Feb. 2016
-> BGDO Course -
Fr. 15 - Sat. 16 April 2016
.....Imaging in Digestive Clinical Applications & Pitfalls

BGDO Annual Meeting 2015 - Hepatocellular Cancer

The presentations are now available View the presentations

Renew today your combined BGDO-ESDO membership 2016

dnetDNET registry

The Digestive Neuroendocrine Tumor registry is a registry to collect epidemiological and medicinal data of patients suffering from digestive neuro-endocrine tumours via an electronic database.

Digestive Neuro-Endocrine Tumours (DNET) are rare and imperfectly understood tumours. The estimated incidence is about 1-2 cases per 100,000 inhabitants and they constitute 2% of all gastrointestinal tumours. These neoplasms can modify amines and synthesize a variety of peptide hormones, which may lead to impressive clinical syndromes. These tumours are also characterized by a relatively slow tumour growth, but nevertheless have a malignant potential.

add a patient nowRegistry goals:

  • To have a better knowledge of the epidemiology of Digestive Neuroendocrine Tumors
  • To understand variations in treatment and treatment related outcomes
  • To assess efficacy of diagnostic techniques and therapeutic strategies
  • To monitor safety of new diagnostic approaches and therapies
  • To improve patient care through feedback of data by giving physicians guidance in diagnosis and treatment policy.

Registry documents click here - Inform consent: Dutch - French

Methodology The data capture of the registry is web-based. A scientific committee has been formed among BGDO members, and with the help of a database company, an interactive registry was created. The DNET registry is open to all members of the BGDO interested in and following patients with DNETs.

The scientific committee and the board of the BGDO strongly encourages all members of the BGDO to include new patients in order to reach the objectives of the registry.

This project cannot be a success without you, but also our partnership with the pharmaceutical companies, i.e. Ipsen, Novartis and Pfizer, which we want to thank also for their support. If you wish to participate to the DNET please contact the Clinical Study Coordinator of the BGDO Nathalie Verbist ( This e-mail address is being protected from spambots. You need JavaScript enabled to view it ). She will help you and explain how to proceed.


FFCD BGDO - Lille  November 2013

Cours intensif de cancerologie digestive

View the presentations

BGDO Oncology Courses
Molecular Biology from GI Cancer: Practical Application in Daily Clinical Practice.

View the presentations

2014 - 2012

Last Updated on Monday, 23 November 2015 13:34
You are here: Home